EBRO 2017

Tra Is the adoption of BRT monotherapy evidence – based?

Brachytherapy (LDR or HDR) as monotherapy = large but retrospective studies. Comparable results with RP or EBRT in terms of bRFS rates.

BRT (LDR or HDR) is included in the NCCN guidelines as a standard therapeutic option for low risk PC, BUT high level evidences based on RCTs are still lacking